Brendan Smith's Stock Ratings

TD Cowen Analyst

Brendan Smith is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025

Updated: Dec 16, 2025

Overall Average Return

5.92%

Smart Score

46.1%

Overall Average Return Percentile

47th

Number of Ratings

11
Buy NowGet Alert
11/04/2025NVAXBuy Now
Novavax
$6.468.28%$8 → $7MaintainsHoldGet Alert
10/29/2025WSTBuy Now
West Pharmaceutical Servs
$268.4930.36% → $350Initiates → BuyGet Alert
09/30/2025SLPBuy Now
Simulations Plus
$19.29-17.03% → $16Initiates → HoldGet Alert
09/20/2024DNABuy Now
Ginkgo Bioworks Holdings
$8.6615.47%$3 → $10MaintainsBuyGet Alert
08/09/2024EXAIBuy Now
Exscientia
DowngradeBuy → HoldGet Alert
08/07/2024HALOBuy Now
Halozyme Therapeutics
$63.312.67%$59 → $65MaintainsBuyGet Alert
07/09/2024EXAIBuy Now
Exscientia
Initiates → BuyGet Alert
05/13/2024NVAXBuy Now
Novavax
$6.4654.68%$5 → $10MaintainsHoldGet Alert
02/29/2024HALOBuy Now
Halozyme Therapeutics
$63.31-14.71% → $54Initiates → OutperformGet Alert
07/21/2023ARWRBuy Now
Arrowhead Pharma
$61.65Initiates → OutperformGet Alert
12/05/2022DNLIBuy Now
Denali Therapeutics
$17.34Initiates → OutperformGet Alert